RecruitingPhase 1NCT07085104
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
Sponsor: Allogene Therapeutics
East Brunswick, NJ · +15 more sites
1 recruiting lupus studies with a site in East Brunswick, NJ.
Sponsor: Allogene Therapeutics
East Brunswick, NJ · +15 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.